Clinical Practice Guidelines: Community-Acquired Pneumonia

CLINICAL PRACTICE GUIDELINES (FULL LIST)

COMMUNITY-ACQUIRED PNEUMONIA (CPG)

Pneumonia is an acute infection of the lower airways caused by both viruses and bacteria. It is one of the most common reasons for childhood hospitalization in the U.S. and the leading killer of children under five worldwide. The guidelines presented here reflect recommendations from the 2011 Pediatric Infectious Diseases Society/Infectious Disease Society of America Consensus Guidelines for the Management of Community-acquired Pneumonia in Children three months to 18 years. They were developed with the express intent of optimizing patient outcomes through the provision of care that is evidence-based and of the highest quality.

Community-acquired pneumonia guidelines team

  • Contact: Sophie Katz, Pediatric Infectious Disease
  • Derek Williams, Hospital Medicine
  • Ritu Banerjee, Infectious Diseases
  • Jessica Gillon, Pharmacy
  • Alison Herndon, Hospital Medicine
  • Bryan Bridges, Critical Care
  • Fred Lamb, Critical Care
  • Michele Walsh, Emergency Medicine
  • Kathryn Carlson, General Pediatrics

References:

  1. Bradley JS et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical guidelines by the Pediatric Infectious Diseases Society and Infectious Diseases Society of America. Clin Infect Dis, 2011. 53(7): e25-76
  2. Williams DJ et al. Short-vs-Standard Course Outpatient Antibiotic Therapy for Community Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial. JAMA Pediatrics,  2022. 176(3): 253-261
  3. Streck HL et al. Evaluation of the Treatment of Aspiration Pneumonia in Hospitalized Children. Journal of the Pediatric Infectious Diseases Society, 2022. 11(3):102-7
  4. Thomson J et al. Antibiotics for Aspiration Pneumonia in Neurologically Impaired Children. J Hosp Med, 2020. 15(7): 395-402.
  5. Parente DM et al. The Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening to Rule Out MRSA Pneumonia: A Diagnostic Meta-analysis with Antimicrobial Stewardship Implications. Clin Infect Dis, 2018. 67(1): 1-7